US companies overusing Medicare outpatient PPS (prospective payment system), say hospitals
This article was originally published in Clinica
Major US hospital groups have begun complaining about the device industry's aggressive use of the special new technology pass-through payment available under Medicare's outpatient prospective payment system (PPS). In a July 10 letter to Thomas Scully, the new administrator of the Centers for Medicare & Medicaid Services (CMS), the groups expressed concern that payments for new technologies might reduce the amount of money going for other care areas.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.